For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| General and administrative costs | 155,513 | |||
| Loss from operations | -155,513 | |||
| Interest earned on cash and investments held in trust account | 109,355 | |||
| Total other income | 109,355 | |||
| Net loss | -46,158 | |||
| Basic EPS | 0 | |||
| Diluted EPS | 0 | |||
| Basic Average Shares | 2,717,391 | |||
| Diluted Average Shares | 2,717,391 | |||
Drugs Made In America Acquisition II Corp. (DMIIU)
Drugs Made In America Acquisition II Corp. (DMIIU)